Prognostic factors in soft tissue sarcoma

Acta Orthopaedica Scandinavica, Supplement

Volumn 68, Issue 273, 1997, Pages 148-155

  Rydholm, Anders ^a  

^a University Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; CYTOSTATIC AGENT;

CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; HUMAN; METASTASIS; MULTIMODALITY CANCER THERAPY; PROGNOSIS; REVIEW; SOFT TISSUE SARCOMA; TUMOR LOCALIZATION; TUMOR NECROSIS; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER INVASION; PATHOLOGY; SARCOMA; SOFT TISSUE TUMOR; TUMOR RECURRENCE;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 0031050364     PISSN: 03008827     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Alho A, Skjeldal S, Melvik J E et al. (1993). The clinical importance of DNA synthesis and aneuploidy in bone and soft tissue tumors. Anticancer Research 13: 2383-8.
2. Alvegård A, Berg NO, Baldetorp B et al. (1990). Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian sarcoma group experience. J Clin Oncol 8: 538-547.
3. Bauer H C F, Kreicbergs A Tribukait B (I991). DNA content prognostic in soft tissue sarcoam. 102 patients followed for 1-10 years Acta Orthop Scand 62: 187-94.
4. Bears O H, Henson D E, Hutter R V P, Myers M H (eds) (1988). American Joint Committee on Cancer: Soft tissues, Chapter 20. Manual for Staging of Cancer, 3rd ed. JB Lippincott, Philadelphia, pp 127-31.
5. Becker R L, Venzon D, Lack E E, et al (1991). Cytometry and morphometry of malignant fibrous histiocytoma of the extremities. Am J Surg Pathol 15(10): 957-64.
6. Bergh P, Berlin OØ, Gunterberg B, et al. (1996). The Gothenburg-Rizzoli joint study on synovial sarcoma. Acta Orthop Scand (SuppI 272): 55-56.
7. Choong P, Åkerman M, Willén H, et al. (1994). Prognostic value af Ki-67 expression in 182 soft tissue sarcomas. Proliferation - a marker of metastasis? APMIS 102: 915-24.
8. Choong P F M, Pritchard D J, Sim F H, et al. ( 1995a). Longterm survival in high grade soft tissue sarcoma. Prognostic factors in synovial sarcoma. Int J Oncol 7(1): 161-9.
9. Choong P, Åkerman M, Rydholm A, et al. (1995b). Proliferating cell nuclear antigen (PCNA) and Ki-67 expression in soft tissue sarcoma. Is prognostic importance histotype specific? APMIS 103: 797-805.
10. Choong P F M, Gustafson P, Rydholm A (1995c). Size and timing of local recurrence predicts metastases in soft tissue sarcoma. Growth rate index retrospectively analyzed in 134 cases. Acta Orthop Scand 66(2): 147-152.
11. Choong PFM, Gustafson P, Willén H et al. (1995d). Prognosis following locally recurrent soft-tissue sarcoma. A staging system based on primary and recurrent tumor characteristics. Int J Cancer 60: 33-37.
12. Choong PFM, Mertens F, Mandahl N et al. (1996). 19 p+ marker chromosome correlates with relapse in malignant fibrous histiocytoma. Genes Chromosom Cancer 16: 88-93.
13. Choong PFM, Femö M, Åkerman M (1996). Urokinase plasminogen activator levels correlate with relapse in soft tissue sarcoma. Int J Cancer 69: 268-72.
14. Coindre J M, Terrier P, Bui N et al. (1996). Prognostic factors in adult patients with locally controlled soft tissue sarcoma: a study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 14: 869-77.
15. Coindre J M, Bui N B, Bonichon F, et al. Histopathologic grading in spindle cell soft tissue sarcomas. Cancer 1988; 61: 2305-9.
16. Dreinhöfer K, Åkerman M, Willén H, et al. (1994). Proliferating cell nuclear antigen (PCNA) in high-grade malignant fibrous hisliocytoma: prognostic value in 48 patients. Int J Cancer 59: 379-82.
17. El-Naggar A K, Ayala A G, Abdul-Karim F, W et al. (1990). Synovial sarcoma. A DNA flow cytomctric study. Cancer 65: 2295-3000.
18. Enneking W F, Spanier S S, Goodman M A ( 1980). A system for the surgical grading of musculoskeletal sarcoma. Clin Orthop 153: 106-20.
19. Fletcher COM (1992). Pleomorphic malignant fibrous histiocytoma: Fact or fiction?: A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 16(3): 213-28.
20. Gustafson P, Rööser B, Rydholm A (1991). Is local recurrence of minor importance for metastases in soft tissue sarcoma? Cancer 67: 2083-6
21. Gustafson P, Rydholm A ( 1992). Selection bias in treatment of soft-tissue sarcoma. J Bone Joint Surg (Br) 74: 501-503.
22. Gustafson P, Dreinhöfer K E, Rydholm A (1993). Metastasis-free survival after local recurrence in soft tissue sarcoma. J Bone Joint Surg (Br) 75; 658-60.
23. Gustafson P. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand 1994; (Suppl 259) 65: 2-31.
24. Gustafson P, Fernö M, Åkerman et al. (19??). Flow cytometric S-phase fraction in soft tissue sarcomas; prognostic importance analysed in 160 pateints. Br J Cancer, in press.
25. Huuthanen R, Blomqvist C, Wiklund T et al. (1996). A high S-phase fraction is a negative prognostic factor for diploid soft tissue sarcomas. Acta Orthop Scand 1996; (Suppl 265) (Abstract): 96.
26. Keen M E, Clevenger C V, Williams T J, et ai. (1985). Correlation of two-color flow cytometric evaluatiuon of smooth muscle tumors with histopathological and clinical parameters. Am J Clin Pathol 83 :401-6.
27. Kuratso S, Tomita Y, Myoui A et al. ( 1995). DNA ploidy pattern and celll cycle stage of tumor sells in soft-tissue sarcomas: clinical implications. Oncology 52: 363-70.
28. Lack E E, Steinberg S M, White D et al. (1989). Extremity soft tissue sarcomas: analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher-grade sarcomas. J Surg Oncol 41(4): 263-73
29. Mandard A M, Petiot J F, Marnay J, et al. (1989). Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases. Cancer 63(7): 1437-51.
30. Merkel DE, McGuire W L (1990). Ploidy, proliferate activity and prognosis. DNA flow cytometry of solid tumors. Cancer 65: 1194-1205.
31. Oda Y, Hashimoto H, Tsuneyoshi M, Takeshita S (1993). Survival in synovial sarcoma. A multivariate study of prognostic factors which special emphasis on the comparison between early death and long-term survival. Am J Surg Pathol 17(1): 35-44.
32. Peabody T D, Monson D, Montag A, et al. ( 1994). A comparison of the prognosis for deep and subcutaneous sarcomas of the extremities. J Bone Joint Surg (Am) 76: 1167-73.
33. Pistcrs P W, Lcung D H, Woodruff J, et al. (1996). Analysis of prognostic factors in 1.041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 14: 1679-89.
34. Rööser B, Attewell R, Rydholm A (1987). The staging of soft-tissue sarcomas. Int Orthop 11: 339-44.
35. Trojani M, Contcsso G, Coindre J M, et al. (1984). Soft tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 33: 37-42.
36. van Unnik J A M, Coindre J M, Contesso C, et al. (1993). Grading of soft tissue sarcomas: experience of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 29A( 15): 2089-93.